Profile for Canada Patent: 2902948
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 2902948
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 11,986,446 | Mar 15, 2033 | Jazz Pharms | XYREM | sodium oxybate |
| 11,986,446 | Mar 15, 2033 | Jazz | XYWAV | calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate |
| 10,213,400 | Sep 15, 2033 | Jazz Pharms | XYREM | sodium oxybate |
| 10,213,400 | Sep 15, 2033 | Jazz | XYWAV | calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate |
| 10,864,181 | Sep 15, 2033 | Jazz Pharms | XYREM | sodium oxybate |
| 10,864,181 | Sep 15, 2033 | Jazz | XYWAV | calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate |
| 11,253,494 | Sep 15, 2033 | Jazz Pharms | XYREM | sodium oxybate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
